Coeptis Therapeutics
Wexford
About Coeptis Therapeutics
Coeptis Therapeutics is a clinical stage biotechnology company developing innovative cell therapy platforms for patients with cancer and other debilitating diseases. It focuses on the development and acquisition of pharmaceutical products. Its pipeline is evolving from the partnerships being created with multiple pharmaceutical companies. As the relationships unfold, the product pipeline will be updated accordingly.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $25.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Aug 2025)
- Ticker: nasdaq:COEP
- Website: coeptistx.com
- Phone: +1 724 934 6467
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/coeptis-therapeutics-84978 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.